OCTREOTIDE 30 MG MICROSPHERE SUSP INJ FAM 1000022035

This tender concerns the procurement of Octreotide 30 mg microsphere suspension for injection, identified by the family code 1000022035. Octreotide is a synthetic analog of the natural hormone somatostatin, primarily used to control symptoms associated with certain types of tumors, such as neuroendocrine tumors (NETs) of the gastrointestinal tract, pancreas, and pituitary gland. It functions by inhibiting the release of various hormones, including growth hormone, insulin, glucagon, and gastrointestinal peptides, thereby managing symptoms like flushing, diarrhea, and abdominal pain. The specific formulation, a 30 mg microsphere suspension for injection, indicates a long-acting depot formulation designed for intramuscular administration, typically given every four weeks. This type of formulation is crucial for maintaining consistent therapeutic levels and improving patient compliance. The tender likely seeks to secure a supply of this essential medication for healthcare facilities or a national drug formulary. Key requirements would typically include adherence to stringent quality standards (e.g., Good Manufacturing Practices - GMP), reliable supply chain management, and potentially specific packaging and labeling requirements. The procurement aims to ensure the availability of this vital treatment for patients suffering from conditions managed by octreotide therapy, underscoring the importance of a stable and high-quality supply chain in pharmaceutical procurement.

This is a supplies contract in the Monitoring Evaluation sector. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the Monitoring Evaluation sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.